Literature DB >> 12139727

SAB--a promising new treatment to improve remission rates in AML in the elderly?

Keith Wheatley1.   

Abstract

This short report presents the results of a comparison of complete remission rates and reasons for failure, between two series of patients aged 60 years or over with acute myeloid leukaemia (AML), and discusses their interpretation.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12139727     DOI： 10.1046/j.1365-2141.2002.03620.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  6 in total

1.  Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Authors: 
Journal:  J Clin Oncol       Date:  2005-08-01       Impact factor: 44.544

2.  Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group.

Authors:  Caitlin W Elgarten; Andrew C Wood; Yimei Li; Todd A Alonzo; Lisa Eidenschink Brodersen; Robert B Gerbing; Kelly D Getz; Y-S Vera Huang; Michael Loken; Soheil Meshinchi; Jessica A Pollard; Lillian Sung; William G Woods; E Anders Kolb; Alan S Gamis; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2021-10-01       Impact factor: 3.167

3.  Applicability of Western protocols in resource-limited setting: Real-world data of long-term outcome of intensive treatment of adult acute myeloid leukaemia in Sri Lanka.

Authors:  Saman Hewamana; Lakmali Kandabadage; Thurairajah Skandarajah; Natasha Pieris; Eranga Perera; Mahesh Harischandra; Ananda Wijewickrama; Chandana Wickramarathna; Gnani Somasundaram; Vadivelu Srinivasan; Surjit Somiah; Priyankara Jayawardena; Mehendra Perera; Dehan Gunasekera; Chathuri Jayasinghe; Godvin Constantine; Sanjeewa Munasinghe; Chandu De Silva; Bandula Wijesiriwardena; Jayantha Balawardena
Journal:  EJHaem       Date:  2021-05-13

4.  Is cytotoxic chemotherapy for lymphoma currently feasible for patients in Malawi? A debate.

Authors:  Emma Crutchlow; Yohannie Miombe; Tom Latham
Journal:  Malawi Med J       Date:  2008-12       Impact factor: 0.875

Review 5.  The blind men and the AML elephant: can we feel the progress?

Authors:  S Tauro
Journal:  Blood Cancer J       Date:  2016-05-13       Impact factor: 11.037

Review 6.  The long shadow of socioeconomic deprivation over the modern management of acute myeloid leukemia: time to unravel the challenges.

Authors:  M Joseph John; Philip Kuriakose; Mark Smith; Eve Roman; Sudhir Tauro
Journal:  Blood Cancer J       Date:  2021-08-06       Impact factor: 11.037
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.